
- Affiliated company
- Former Board Member (2022 - 2024)Pixium Vision
August Moretti is the Chief Financial Officer of 4D Molecular Therapeutics, a publicly held gene therapya medical approach that treats or prevents disease by changing genetic material in cells company. Prior to this role, he served as CFO of Assertio Therapeutics, a publicly held specialty pharmaceutical company, and before that he was CFO of Alexza Pharmaceuticals, a publicly held life science company. Mr. Moretti began his career practicing corporate and securities law. He received his JD degree from Harvard Law School and a Bachelor’s degree in Economics from Princeton University.
Experience
Education
Harvard Law SchoolJD1972 - 1975
Princeton UniversityAB, Economics1968 - 1972
Article information
How verification worksNot yet verified. This page has not been verified by an expert yet, so the information presented here may be incomplete or inaccurate.
Last updated January 02, 2024 at 6:58 PM.
The following people contributed to this page:
- Michael BeyelerAssociate Professor, UC Santa Barbara

